Net Cash Provided by (Used in) Operating Activities |
-2.17K |
USD |
+82.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
49.2K |
USD |
+140% |
Q1 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
80M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
5.2M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.17K |
USD |
+82.2% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
77.2K |
USD |
+10.6% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
77.2K |
USD |
+10.6% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
1.23M |
USD |
0% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Interest Expense |
3.8K |
USD |
+64.9% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |